KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹120 Cr | ₹108 Cr | ₹93 Cr | ₹80 Cr | ₹62 Cr |
What is the latest Revenue of KERALA AYURVEDA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹108 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹62 Cr |
How is Revenue of KERALA AYURVEDA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | 11.57 | |
| Mar2024 | ₹108 Cr | 15.46 | |
| Mar2023 | ₹93 Cr | 16.25 | |
| Mar2022 | ₹80 Cr | 29.45 | |
| Mar2021 | ₹62 Cr | - | |
Compare Revenue of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹252.4 Cr | -8.1% | -12.1% | -49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -8.1% |
-12.1% |
-49.1% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses